For example, while TGFb is a potent modulator of macrophage and fibroblast phenotypes [13], genetic knockout of TGFb receptor components in different populations demonstrated that blocking TGFb responses only in T cells was sufficient to improve tumor control in pre-clinical models [14]. Here, TGFB1 is linked to neoplasm.